What's in DURECT Corporation's pipeline?

DURECT Corporation has 7 drugs in our index: 0 marketed, 0 filed, 1 in Phase 3, 6 in Phase 2, 0 in Phase 1.

Which companies overlap with DURECT Corporation's portfolio?

Top competitors by shared drug class: Ain Shams Maternity Hospital, Ain Shams University, Aligarh Muslim University, Anavex Life Sciences Corp., Atlantic Health System.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/durect.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-13 · How we verify

DURECT Corporation — Portfolio Competitive Intelligence Brief

DURECT Corporation (DRRX) pipeline: 0 marketed, 0 filed, 1 Phase 3, 6 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

DRRX (NASDAQ) 0 marketed 0 filed 1 Phase 3 6 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
SABER-Bupivacaine	SABER-Bupivacaine	phase 3	Local anesthetic		Pain management

Therapeutic area mix

Pain management · 2
Anesthesiology · 1
Pain · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Ain Shams Maternity Hospital · 1 shared drug class
Ain Shams University · 1 shared drug class
Aligarh Muslim University · 1 shared drug class
Anavex Life Sciences Corp. · 1 shared drug class
Atlantic Health System · 1 shared drug class
Aultman Health Foundation · 1 shared drug class
B.P. Koirala Institute of Health Sciences · 1 shared drug class
Abant Izzet Baysal University · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for DURECT Corporation:

Cite this brief

Drug Landscape (2026). DURECT Corporation — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/durect. Accessed 2026-05-13.